Variant report

Variant	nsv6121
Chromosome Location	chr10:26683702-26697307
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr10:26692597..26693117-chr4:171403756..171404276,2	MCF-7	breast:
2	chr10:26692097..26692617-chr11:21332888..21333408,2	MCF-7	breast:
3	chr10:26692097..26692617-chr17:50247612..50248132,2	MCF-7	breast:
4	chr10:26692097..26692617-chr4:116457976..116458496,2	MCF-7	breast:
5	chr10:26692597..26693117-chr2:31059867..31060387,2	MCF-7	breast:
6	chr10:26692097..26692617-chr4:146024840..146025360,2	MCF-7	breast:

Extended variants
information (count: 609 )
Associated
traits (count: 40 )

Variant overlapped rSNPs/rCNVs (count:609 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs563147838	chr10:26683707-26683708	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs373712678	chr10:26683727-26683728	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs533014830	chr10:26683733-26683734	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs192649580	chr10:26683764-26683765	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs150569614	chr10:26683793-26683794	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs566002736	chr10:26683820-26683821	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs2992292	chr10:26683822-26683823	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs184126520	chr10:26683823-26683824	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs571251817	chr10:26683839-26683840	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs550460251	chr10:26683850-26683851	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs557046841	chr10:26683909-26683910	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs186633572	chr10:26683943-26683944	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs536013676	chr10:26684051-26684052	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs532364566	chr10:26684084-26684085	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs3006778	chr10:26684092-26684093	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs572745660	chr10:26684139-26684140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs541317095	chr10:26684147-26684148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs556551774	chr10:26684154-26684155	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs544221114	chr10:26684196-26684197	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs149379964	chr10:26684198-26684199	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs557683729	chr10:26684366-26684367	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs543533837	chr10:26684379-26684380	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs11015086	chr10:26684463-26684464	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs191086597	chr10:26684486-26684487	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs560378792	chr10:26684515-26684516	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs10659787	chr10:26684527-26684528	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs56392511	chr10:26684528-26684529	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs72031564	chr10:26684537-26684538	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs559277208	chr10:26684553-26684554	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs528425353	chr10:26684554-26684555	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs58702827	chr10:26684596-26684597	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs551659371	chr10:26684600-26684601	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs59172364	chr10:26684605-26684606	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs531425754	chr10:26684612-26684613	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs564875336	chr10:26684615-26684616	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs58084468	chr10:26684647-26684648	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs373508203	chr10:26684653-26684654	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs376979702	chr10:26684662-26684663	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs370263323	chr10:26684673-26684674	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs550709463	chr10:26684681-26684682	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs373748296	chr10:26684695-26684696	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs386742126	chr10:26684700-26684701	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs386742127	chr10:26684706-26684707	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs367869690	chr10:26684763-26684764	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs370505396	chr10:26684768-26684769	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs567389232	chr10:26684773-26684774	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs113744606	chr10:26684780-26684781	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs115715792	chr10:26684781-26684782	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs144185981	chr10:26684795-26684796	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs372717322	chr10:26684796-26684797	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:40)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Autism	21439084	CNVD
Maculopathy	20981449	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Adrenocortical carcinoma	18281524	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:26 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:26681600-26688200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr10:26681600-26694200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
3	chr10:26683600-26683800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
4	chr10:26684000-26684200	Enhancers	iPS-18 Cell Line	embryonic stem cell
5	chr10:26689200-26689400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr10:26694200-26694400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr10:26694200-26694400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
8	chr10:26694400-26694600	Enhancers	A549	lung
9	chr10:26694400-26696400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr10:26694800-26696000	Weak transcription	A549	lung
11	chr10:26695400-26696600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr10:26695600-26696000	Enhancers	NHDF-Ad	bronchial
13	chr10:26696000-26696400	Weak transcription	NHDF-Ad	bronchial
14	chr10:26696000-26696600	Enhancers	A549	lung
15	chr10:26696000-26697200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr10:26696400-26696600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr10:26696400-26697200	Enhancers	NHDF-Ad	bronchial
18	chr10:26696400-26699600	Enhancers	GM12878-XiMat	blood
19	chr10:26696600-26697000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
20	chr10:26696600-26697000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
21	chr10:26696600-26697000	Flanking Active TSS	A549	lung
22	chr10:26696600-26697200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr10:26696600-26697400	Enhancers	Monocytes-CD14+_RO01746	blood
24	chr10:26696800-26698400	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr10:26697000-26697600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr10:26697000-26699600	Enhancers	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links